New Drug Application

December 28, 2009

Iluvien® For Diabetic Macular Edema Has Eyes on FDA

Alimera's Iluvien proving effective in phase 3 clinical trials. Iluvien will release fluocinolone acetonide for the treatment of diabetic macular edema. Iluvien is an injectable extended release delivery system.
March 17, 2010

Iluvien: New Drug for Diabetic Macular Edema

Iluvien, an injectable drug delivery system, gets one step closer to be the first drug FDA approved for the treatment of diabetic macular edema.
July 1, 2010

Iluvien Treatment for Diabetic Macular Edema

Iluvien nears FDA approval and is likely to be the first injectable,sustained release drug delivery system for the treatment of diabetic macular edema.
May 18, 2011

Alimera Sciences Says Iluvien Effective at 3 Years

Iluvien, a sustained release intraocular drug delivery system, may get closer to FDA approval. The parent company just submitted additional safety/efficacy data as requested by the FDA.